VOLTAN, Rebecca
 Distribuzione geografica
Continente #
NA - Nord America 4.597
EU - Europa 1.368
AS - Asia 774
OC - Oceania 4
SA - Sud America 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.747
Nazione #
US - Stati Uniti d'America 4.594
IT - Italia 411
CN - Cina 363
PL - Polonia 246
UA - Ucraina 217
DE - Germania 184
SG - Singapore 164
TR - Turchia 126
GB - Regno Unito 102
SE - Svezia 58
ID - Indonesia 54
FI - Finlandia 52
VN - Vietnam 29
FR - Francia 24
CZ - Repubblica Ceca 15
RU - Federazione Russa 15
HK - Hong Kong 14
NL - Olanda 11
BE - Belgio 8
IE - Irlanda 7
KR - Corea 7
IN - India 6
AU - Australia 4
BG - Bulgaria 3
ES - Italia 3
IR - Iran 3
JP - Giappone 3
TW - Taiwan 3
AL - Albania 2
CH - Svizzera 2
MX - Messico 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
BR - Brasile 1
CA - Canada 1
CL - Cile 1
DK - Danimarca 1
GR - Grecia 1
IL - Israele 1
KE - Kenya 1
LU - Lussemburgo 1
MC - Monaco 1
MD - Moldavia 1
NO - Norvegia 1
Totale 6.747
Città #
Fairfield 722
Woodbridge 603
Houston 390
Ashburn 323
Chandler 303
Seattle 280
Ann Arbor 279
Cambridge 268
Jacksonville 266
Wilmington 246
Warsaw 242
Ferrara 222
Singapore 108
Izmir 87
Beijing 85
Boardman 72
Nanjing 68
Princeton 61
New York 58
Jakarta 54
San Diego 46
Shanghai 42
Milan 38
Dong Ket 29
Falls Church 27
Los Angeles 25
Bremen 24
Nanchang 22
Shenyang 20
Bologna 19
Hebei 18
Dearborn 16
London 16
Brno 15
Changsha 14
Santa Clara 14
Norwalk 13
Hong Kong 12
Kunming 12
Washington 12
Jiaxing 10
Mountain View 9
Orange 9
Tappahannock 9
Tianjin 9
Auburn Hills 8
Brussels 8
Redwood City 8
Imola 7
Rome 7
Taizhou 7
Chicago 6
Dronten 6
Jinan 6
Munich 6
San Mateo 6
Augusta 5
Ferrara di Monte Baldo 5
Guangzhou 5
Nam-gu 5
Ningbo 5
Catania 4
Des Moines 4
Forlì 4
Gdansk 4
Haikou 4
Rimini 4
Zhengzhou 4
Ardabil 3
Cattolica 3
Helsinki 3
Padova 3
Turin 3
Varna 3
Agropoli 2
Cagliari 2
Castel San Pietro Terme 2
Changchun 2
Cheongju-si 2
Chiswick 2
Hangzhou 2
Hefei 2
Lanzhou 2
Lappeenranta 2
Leawood 2
Naples 2
New Delhi 2
Parma 2
Redmond 2
Reggio Emilia 2
Rennes 2
Saint-Fons 2
San Vitaliano 2
Sommacampagna 2
Taipei 2
Tokyo 2
Verona 2
Walnut 2
Zurich 2
Acton 1
Totale 5.414
Nome #
Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model 180
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 165
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 157
Expeditious Synthesis and Biological Characterization of Enantio-Enriched (-)-Nutlin-3 156
Serum From Advanced Heart Failure Patients Promotes Angiogenic Sprouting and Affects the Notch Pathway in Human Endothelial Cells 155
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 154
MDM2/X inhibitors under clinical evaluation: Perspectives for the management of hematological malignancies and pediatric cancer 151
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 146
HelixComplex snail mucus exhibits pro-survival, proliferative and pro-migration effects on mammalian fibroblasts 140
Multiple dye-doped NIR-emitting silica nanoparticles for both flow cytometry and in vivo imaging 139
Proper design of silica nanoparticles combines high brightness, lack of cytotoxicity and efficient cell endocytosis 130
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 130
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 127
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53(wild-type) JVM-2 But Not Towards p53(mutated) BJAB Leukemic Cells 126
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 126
Clinical perspectives of TRAIL: Insights into central nervous system disorders 122
Redox signaling and oxidative stress: Cross talk with TNF-related apoptosis inducing ligand activity 119
Actively targeted nanocarriers for drug delivery to cancer cells 117
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS 114
Anti-leukemic activity of Dasatinib in both p53(wild-type) and p53 (mutated) B malignant cells. 111
Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag. 110
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 110
null 103
Nutlin-3 differentially modulates miRNA34a and miRNA181 versus miR26a and miR155 in p53 proficient and p53 deficient B chronic lymphocytic leukemia (B-CLL) samples 103
Heterogeneity of mesenchymal stromal cells in lymphoproliferative disorders 102
null 101
Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice 101
null 100
Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells 99
The oncogene DEK promotes leukemic cell survival and is downregulated by both nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cells 99
Live recombinant vectors for AIDS vaccine development 99
null 97
Rhesus macaque resistance to mucosal simian immunodeficiency virus infection is associated with a postentry block in viral replication 97
The gamma-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells 97
null 94
Anticancer Activity of Aqueous Extracts from Asparagus officinalis L. Byproduct on Breast Cancer Cells 94
null 92
Perspectives of protein kinase C (PKC) inhibitors as anti-cancer agents 92
Applications of nanoparticles in cancer medicine and beyond: optical and multimodal in vivo imaging, tissue targeting and drug delivery 92
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib. 90
Replicating Ad-recombinants encoding non-myristoylated rather than wild-type HIV Nef elicit enhanced cellular immunity. 90
null 90
null 90
null 89
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 89
null 88
SRP-35, a newly identified protein of the skeletal muscle sarcoplasmic reticulum, is a retinol dehydrogenase 87
p53 and merlin tumor suppressors: Two of a kind 87
null 86
null 86
null 84
Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes. 83
null 83
null 81
null 74
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors 57
Netter's Introduzione all'imaging 55
null 55
Antitumoral activity of Asparagus officinalis extracts against breast cancer 47
null 43
null 42
Cell cycle block by p53 acrivation reduces SARS-COV-2 release in infected alveolar basal epithelial A549-hACE2 cells 39
DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of HIV-1 tat DNA vaccination 37
Use of bioactives from agrifood by-products in topical cosmetic hydrogels 36
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia 34
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members 28
Activation of the p53 pathway induces α-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages 26
In vitro endothelial cell proliferation assay reveals distinct levels of proangiogenic cytokines characterizing sera of healthy subjects and of patients with heart failure 26
Dasatinib plus Nutlin-3 shows synergistic anti-leukemic activity in both p53wild-type and p53mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway. 23
Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activity. 23
miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. 22
Human Full-Length Osteoprotegerin Induces the Proliferation of Rodent Vascular Smooth Muscle Cells both in vitro and in vivo 21
Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin 21
Characterization of HIV-1 Tat proteins mutated in the transactivation domain for prophylactic and therapeutic application 19
Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotype. 18
Nutrients, herbal bioactive derivatives and commensal microbiota as tools to lower the risk of SARS-CoV-2 infection 17
MDM2 inhibitors counteract inflammation by stabilization of ACE2 in vitro 15
Ethosomes nanodelivery of the MDM2 inhibitor Nutlin-3a efficiently induces cells death in melanoma 15
State of the art of the therapeutic perspective of sorafenib against hematological malignancies 15
null 15
MDM2 inhibitors-mediated disruption of mitochondrial metabolism: A novel therapeutic strategy for retinoblastoma 14
Asparagus officinalis L. aqueous extracts mediate cell cycle block and migration inhibition in breast cancer cells 14
Nutlin-3 downregulates the expression of the Oncogene TCL1 in primary B Chronic Lymphocytic Leukemic cells. 14
Selective induction of TP53I3/p53-inducible gene 3 (PIG3) in myeloid leukemic cells, but not in normal cells, by Nutlin-3 14
Oscillatory turbulent flow in chronic venous disease induces pro-inflammatory and reparative biological signaling 14
Nanoparticles engineered with Rituximab and loaded with Nutlin-3 show promising therapeutic activity in B leukemic xenografts 12
Induction of humoral and enhanced cellular immune responses by novel core-shell nanosphere- and microsphere-based vaccine formulations following systemic and mucosal administration 12
Cell cycle block by p53 activation reduces SARS-CoV-2 release in A549-hAce2 cells 11
MDM2 non-genotoxic inhibitors as innovative therapeutic approaches for the treatment of pediatric malignancies 10
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 10
Characterization Methods for Nanoparticle–Skin Interactions: An Overview 9
Therapeutic potential of the MDM2 inhibitor Nutlin-3 in counteracting SARS-CoV-2 infection of the eye through p53 activation 9
Nutlin-3a-loaded ethosomes as a delivery system in vitro to Target p53 in melanoma 8
Nutlin-3 Loaded Ethosomes and Transethosomes to Prevent UV-Associated Skin Damage 8
Totale 6.932
Categoria #
all - tutte 29.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.040


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.262 0 0 57 234 114 166 155 167 139 134 59 37
2020/20211.304 64 105 39 105 117 139 93 136 58 238 131 79
2021/2022719 25 75 57 37 89 45 44 28 31 54 71 163
2022/2023767 66 48 32 91 108 98 35 66 99 32 56 36
2023/2024544 57 43 20 15 29 74 21 58 17 16 42 152
2024/2025298 62 75 161 0 0 0 0 0 0 0 0 0
Totale 6.932